Nature's Sunshine Products (NATR) Competitors $16.00 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NATR vs. CMRX, FBIO, HLF, USNA, NUS, MED, VERU, EL, IPAR, and PBHShould you be buying Nature's Sunshine Products stock or one of its competitors? The main competitors of Nature's Sunshine Products include Chimerix (CMRX), Fortress Biotech (FBIO), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), and Prestige Consumer Healthcare (PBH). Nature's Sunshine Products vs. Chimerix Fortress Biotech Herbalife USANA Health Sciences Nu Skin Enterprises Medifast Veru Estée Lauder Companies Inter Parfums Prestige Consumer Healthcare Chimerix (NASDAQ:CMRX) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends. Do analysts recommend CMRX or NATR? Chimerix presently has a consensus price target of $8.50, suggesting a potential upside of 888.49%. Nature's Sunshine Products has a consensus price target of $19.00, suggesting a potential upside of 18.75%. Given Chimerix's higher probable upside, research analysts clearly believe Chimerix is more favorable than Nature's Sunshine Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chimerix 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Nature's Sunshine Products 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer CMRX or NATR? Chimerix received 224 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 63.62% of users gave Chimerix an outperform vote while only 63.60% of users gave Nature's Sunshine Products an outperform vote. CompanyUnderperformOutperformChimerixOutperform Votes39063.62% Underperform Votes22336.38% Nature's Sunshine ProductsOutperform Votes16663.60% Underperform Votes9536.40% Does the media prefer CMRX or NATR? In the previous week, Chimerix had 3 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 9 mentions for Chimerix and 6 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.21 beat Chimerix's score of 0.59 indicating that Nature's Sunshine Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chimerix 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nature's Sunshine Products 1 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CMRX or NATR? Chimerix has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, Nature's Sunshine Products has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Is CMRX or NATR more profitable? Nature's Sunshine Products has a net margin of 3.81% compared to Chimerix's net margin of 0.00%. Nature's Sunshine Products' return on equity of 11.08% beat Chimerix's return on equity.Company Net Margins Return on Equity Return on Assets ChimerixN/A -50.78% -44.94% Nature's Sunshine Products 3.81%11.08%7.23% Which has stronger valuation & earnings, CMRX or NATR? Nature's Sunshine Products has higher revenue and earnings than Chimerix. Chimerix is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChimerix$320K241.69-$82.10M-$0.94-0.91Nature's Sunshine Products$445.32M0.66$15.08M$0.8818.18 Do insiders & institutionals have more ownership in CMRX or NATR? 45.4% of Chimerix shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 13.1% of Chimerix shares are held by company insiders. Comparatively, 4.7% of Nature's Sunshine Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryNature's Sunshine Products beats Chimerix on 10 of the 17 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Nature's Sunshine Products News Delivered to You Automatically Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NATR vs. The Competition Export to ExcelMetricNature's Sunshine ProductsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$295.68M$6.49B$5.13B$8.74BDividend YieldN/A8.15%5.18%4.07%P/E Ratio18.184.8266.7313.27Price / Sales0.66374.171,265.2981.14Price / Cash10.0151.8140.2135.77Price / Book1.829.636.455.92Net Income$15.08M$154.43M$119.73M$225.73M7 Day Performance7.38%-9.46%-5.13%-1.34%1 Month Performance19.94%-7.27%-2.71%1.15%1 Year Performance-8.83%28.13%31.08%24.02% Nature's Sunshine Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NATRNature's Sunshine Products2.9504 of 5 stars$16.00flat$19.00+18.8%-7.1%$295.62M$445.32M18.18814Positive NewsCMRXChimerix4.4465 of 5 stars$0.88-2.1%N/A-14.0%$79.15M$320,000.00-0.9472Short Interest ↓FBIOFortress Biotech3.1706 of 5 stars$1.57-4.8%N/A+0.0%$35.81M$84.51M-0.49186Analyst DowngradeNews CoverageHLFHerbalife4.0638 of 5 stars$7.72-5.9%N/A-37.6%$777.60M$5.06B9.089,200Gap UpUSNAUSANA Health Sciences2.8527 of 5 stars$39.44-3.6%N/A-11.8%$751.73M$921.01M13.941,800NUSNu Skin Enterprises4.0068 of 5 stars$7.19-3.9%N/A-57.3%$357.34M$1.97B-3.473,700MEDMedifast2.59 of 5 stars$18.30-6.5%N/A-72.7%$200.20M$1.07B27.73870Positive NewsVERUVeru2.6645 of 5 stars$0.64+1.8%N/A-41.6%$93.68M$16.30M-1.33189Positive NewsELEstée Lauder Companies4.8834 of 5 stars$64.99+0.2%N/A-48.0%$23.33B$15.61B116.0562,000Short Interest ↑IPARInter Parfums4.4193 of 5 stars$130.72+2.0%N/A-1.8%$4.19B$1.32B28.05530Analyst ForecastShort Interest ↑Analyst RevisionNews CoveragePBHPrestige Consumer Healthcare3.7771 of 5 stars$82.81+0.6%N/A+39.6%$4.09B$1.13B20.15540Insider SellingAnalyst Revision Related Companies and Tools Related Companies CMRX Alternatives FBIO Alternatives HLF Alternatives USNA Alternatives NUS Alternatives MED Alternatives VERU Alternatives EL Alternatives IPAR Alternatives PBH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NATR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nature's Sunshine Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nature's Sunshine Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
